AKARI THERAPEUTICS Trademark

Trademark Overview

On Sunday, July 12, 2015, a trademark application was filed for AKARI THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the AKARI THERAPEUTICS trademark a serial number of 86690614. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 28, 2023. This trademark is owned by Celsus Therapeutics Plc. The AKARI THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

drug discovery services, product research and development in the fields of pharmaceuticals and biotechnology, pharmaceuticals to treat rare orphan conditions
akari therapeutics

General Information

Serial Number86690614
Word MarkAKARI THERAPEUTICS
Filing DateSunday, July 12, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 28, 2023
Registration Number5065372
Registration DateTuesday, October 18, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 29, 2016

Trademark Statements

Translation of Words in MarkThe English translation of the word "AKARI" in the mark is "LIGHT".
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and Servicesdrug discovery services, product research and development in the fields of pharmaceuticals and biotechnology, pharmaceuticals to treat rare orphan conditions

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 28, 2023
Primary Code042
First Use Anywhere DateTuesday, June 14, 2016
First Use In Commerce DateTuesday, June 14, 2016

Trademark Owner History

Party NameAKARI THERAPEUTICS PLC
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLONDON W1G 9RS
GB
Party NameAKARI THERAPEUTICS PLC
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressLONDON W1G 9RS
GB
Party NameCelsus Therapeutics Plc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLondon W1K5JH
GB
Party NameCelsus Therapeutics Plc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLondon W1K5JH
GB

Trademark Events

Event DateEvent Description
Friday, April 28, 2023CANCELLED SEC. 8 (6-YR)
Monday, October 18, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, April 14, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 14, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 14, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 18, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, September 13, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, September 12, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 23, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 22, 2016STATEMENT OF USE PROCESSING COMPLETE
Monday, July 25, 2016USE AMENDMENT FILED
Monday, August 22, 2016SOU EXTENSION 1 GRANTED
Monday, July 25, 2016SOU EXTENSION 1 FILED
Friday, August 19, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 25, 2016TEAS EXTENSION RECEIVED
Monday, July 25, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, May 24, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 27, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, March 29, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 29, 2016PUBLISHED FOR OPPOSITION
Wednesday, March 9, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 22, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, February 16, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 16, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 16, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 8, 2016ASSIGNED TO LIE
Monday, February 8, 2016ASSIGNED TO LIE
Tuesday, February 2, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 28, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 28, 2015NON-FINAL ACTION E-MAILED
Wednesday, October 28, 2015NON-FINAL ACTION WRITTEN
Wednesday, October 28, 2015LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Monday, October 26, 2015LETTER OF PROTEST EVIDENCE FORWARDED
Wednesday, October 21, 2015ASSIGNED TO EXAMINER
Thursday, July 16, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 15, 2015NEW APPLICATION ENTERED

Related Keywords

therapeutics akari pharmaceuticals biotechnology treat orphan conditions rare fields services discovery product